Summary

In this conversation, psychedelic guide Daniel McQueen shares his journey from Arkansas to Boulder, where he pioneered the intentional use of cannabis as a psychedelic. He explains how cannabis, when paired with set, setting, posture, terpene blends, and CBN, can reliably induce psychedelic states and mimic the effects of MDMA, mushrooms, or LSD. The discussion covers the continuum of psychedelic use for trauma healing and transformation, emphasizing sequencing treatments with ketamine, cannabis, and psilocybin before exploring advanced medicines like DMT. Daniel also highlights the risks of untrained guides, stressing the importance of ethics, training, and integration. The conversation expands into the frontier of DMTX (extended-state DMT), where continuous infusion enables hours-long journeys beyond the typical short DMT blast. Themes of healing, safety, personal growth, and exploration anchor the discussion, underscoring psychedelics as both powerful tools for trauma resolution and advanced practices for consciousness exploration.

Takeaways

• Daniel studied transpersonal counseling at Naropa, intending to be an underground psychedelic guide.
• Cannabis became his primary tool after Colorado’s legalization in 2014.
• Cannabis, when used intentionally, can function as a psychedelic “shape-shifter.”
• Combining indica, sativa, hybrid, and CBN enhances psychedelic effects while reducing anxiety.
• Cannabis resembles MDMA by softening the amygdala and enabling trauma reconsolidation.
• Healing is best approached as a path, not a one-time cure.
• Recommended sequence: ketamine → cannabis → mushrooms/DMT.
• Psychedelics amplify what is present — resolving trauma first prevents overwhelm.
• True guiding requires training, ethics, screening, and integration; giving the medicine is only 10% of the role.
• Untrained guides risk harm, consent violations, and misuse of power.
• Negative outcomes include amplified psychosis, mania, or dissociation if misused.
• Integration is crucial to ensure experiences heal rather than reinforce unhealthy patterns.
• Future therapy may use personalized medicine “recipes” and precise dosing.
• DMTX enables hours-long DMT states, moving psychedelics beyond healing into exploration.
• Cannabis is scalable and accessible; DMTX is advanced and niche.
• Both represent the spectrum of what psychedelics can offer humanity.

Chapters

00:00 – Introduction & Background
02:04 – Becoming a Psychedelic Guide
03:30 – Legalization and Cannabis as Psychedelic
05:12 – Edibles, Anxiety, and Terpenes
08:51 – Blending Strains and Adding CBN
10:36 – Trauma Release and Memory Reconsolidation
11:52 – Cannabis on the Psychedelic Spectrum
15:19 – Sequencing Psychedelics for Healing
17:27 – Cannabis as MDMA-Like Therapy
19:32 – Daily Use vs. Intentional Use
21:27 – Harm Reduction & Addiction Support
22:38 – Ibogaine, Risks, and State Legalization
25:33 – The Future: Personalized Psychedelic Protocols
27:25 – Dosing, Safety, and Overuse Risks
29:10 – Screening, Ethics, and Community Responsibility
31:05 – Negative Outcomes and Abuse of Power
34:13 – River Analogy: The True Role of Guides
36:40 – Integration as Essential to Healing
39:16 – Paranoia, Safety, and Crisis Management
41:08 – Checklists, Training, and Professionalism
44:41 – Intuition vs. Ethics in Guiding
47:45 – Introduction to DMTX
49:35 – Continuous Infusion and Extended DMT States
51:55 – Comparing DMTX to Traditional DMT
53:26 – Hours-Long Journeys and Exploration Potential

Podcast: Play in new window | Download